Establishment Labs Holdings (ESTA) Cash & Current Investments (2022 - 2026)

Establishment Labs Holdings' (ESTA) quarterly Cash & Current Investments came in at $68.1 million in Q1 2026, up 4156.31% year-on-year from $1.6 million in Q1 2025, and up 7466.78% quarter-over-quarter from $900000.0 in Q3 2025.

Establishment Labs Holdings (ESTA) Cash & Current Investments (2022 - 2026) Analysis & Trends

Establishment Labs Holdings' Cash & Current Investments history runs 5 years deep, the most recent figure standing at $68.1 million for Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 4156.31% year-over-year to $68.1 million in Q1 2026; TTM through Mar 2026 was $68.1 million, a 4156.31% increase from a year earlier, with the FY2024 full-year figure at $3.0 million, down 92.51% from the prior year.
  • Cash & Current Investments advanced to $68.1 million in Q1 2026 per ESTA's latest filing, from $900000.0 in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $68.1 million in Q1 2026 and bottomed at $900000.0 in Q3 2025.
  • The 5-year median for Cash & Current Investments is $40.0 million (2023), against an average of $33.5 million.
  • Across the five-year window, Cash & Current Investments tumbled 92.51% in 2024 and soared 4156.31% in 2026, its largest moves.
  • Year by year, Cash & Current Investments stood at $66.4 million in 2022, then tumbled by 39.67% to $40.0 million in 2023, then tumbled by 92.51% to $3.0 million in 2024, then sank by 70.0% to $900000.0 in 2025, then jumped by 7466.78% to $68.1 million in 2026.
  • Per Business Quant, the three latest ESTA Cash & Current Investments figures stand at $68.1 million (Q1 2026), $900000.0 (Q3 2025), and $54.6 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 7.30 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 2.88 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 3.67 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 1.12 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.29 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 577.00 Mn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 3.12 Bn
10 Establishment Labs Holdings 2.75 Bn 2.68 Bn 42.34 Mn 68.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 68.10 Mn
Sep 30, 2025 900,000.00
Jun 30, 2025 54.64 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 3.00 Mn
Dec 31, 2023 40.04 Mn
Dec 31, 2022 66.36 Mn